AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2020
Dec 11, 2020
34519_dirs_2020-12-11_569c0709-5d0a-4935-af37-ad569c0c0a31.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2020-12-08
Reporting Person: Brockmann Bobbi Jo (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-08 | Common Stock, par value $0.10 per share | A | 4742.0000 | $3.1500 | Acquired | 8521.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-12-08 | Incentive Stock Options (Right to buy) | $3.1500 | D | 5258.0000 | Disposed | 2020-12-14 | Common Stock (5258.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
Jun 10
Report Publication Announcement
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25